Hutchinson Institute for Cancer Outcomes Research

Upcoming Events:

Value in Cancer Care Summit
March 30, 2015, Pelton Auditorium

Recent Events and Talks

The Hutchinson Institute for Cancer Outcomes Research, or HICOR, takes an innovative approach to improve the effectiveness of cancer prevention, treatment and therapy while stemming the high costs of cancer care.

HICOR Director Dr. Scott Ramsey and Co-Director Dr. Gary Lyman, both members in the Cancer Prevention Program in the Public Health Sciences Division at Fred Hutch, lead a multidisciplinary team that works with multiple partners – patients, physicians and payers. HICOR bridges research and clinical practice to develop strategies for improving the quality of cancer patient care while bringing down the costs.

Cancer-care costs are projected to reach nearly $175 billion annually by 2020 and a growing portion of that price tag will be borne by patients. Studies show those diagnosed with cancer are more than twice as likely to declare bankruptcy due to skyrocketing costs of treatment and medication than those who are not. Yet, this higher spending doesn’t translate to increased life expectancy.

“It is because of the unsustainable rise in the costs of cancer care, including that related to drugs and aggressive and often unnecessary imaging procedures, that HICOR has taken on the charge,” said Lyman.

Value in Cancer Care Initiative

Fred Hutch, along with a coalition of provider groups, health insurers, and businesses are jointly launching a statewide Value in Cancer Care Initiative.

Learn more >

The rising costs of healthcare spending

US healthcare spending and cancer treatment costs are increasing, but patient outcomes are not improving. How does that compare with the rest of the world?

Learn more >

What are HICOR's research priorities?

HICOR faculty are researching everything from the financial impact of cancer to the value of data and information to what teatments result in best outcomes. 

Learn more >